The British Journal Of Obstetrics and Gynaecology

Fewer cases were submitted than predicted; many were submitted without documented symptoms. Cases may have been missed as symptoms were not documented or misdiagnosed reducing the calculated incidence.

Recording fluid balance and targeted blood tests to measure serum sodium levels may help an earlier diagnosis.

Fluid intake, particularly excessive drinking is a known cause of hyponatraemia but was poorly recorded. There was a higher than expected incidence in women using birthing pools and transferring from home birth settings.

Some babies had hyponatraemic seizures even when their mothers had no documented symptoms.

First national study of peripartum hyponatraemia using UK's national obstetric surveillance system shows that this condition is often unrecognised but can cause harm to women and their babies around labour and birth.

OBGYN Objective To determine the national incidence, characteristics, management and outcomes of peripartum hyponatraemia. Design Prospective, observational study using United Kingdom (UK) Obstetric Sur...

The Incidence, Characteristics, Management and Outcomes of Peripartum Hyponatraemia in the United Kingdom: A Prospective Study Using the UK Obstetric Surveillance System (UKOSS)

obgyn.onlinelibrary.wiley.com/doi/abs/10.1...

OBGYN Objective To investigate if second trimester pregnancy loss (second trimester miscarriage [STM] or termination for medical reasons [TFMR]) was associated with subsequent adverse pregnancy outcomes. ...

Pregnancy Outcomes After Second Trimester Pregnancy Loss & Termination for Medical Reasons Before 24 Weeks: A Historical Cohort Study [PASTeL-2]

Andrea Woolner, Konstantin Shestopaloff, Alexander Heazell @mcr-sb-research.bsky.social

obgyn.onlinelibrary.wiley.com/doi/full/10....

@bjog.bsky.social

Who gets menopause treatment – and who is left out? Hormone replacement therapy (HRT) is one of the most effective treatments for menopausal symptoms, yet a major new international study led by researchers from the Nuffield Department of Primary Care H...

"Too often, women’s background or health status appears to influence whether they are offered or take up HRT."

New research by @drjenny-hirst.bsky.social in @bjog.bsky.social shows that background, health & access to care all influence who uses #HRT rather than decisions shaped by women's needs 👇

If you're prescribed/ advised to take aspirin in pregnancy, don’t hesitate to ask your care team for support!

If you’ve been told to take aspirin during pregnancy, it can help reduce the risk of pre-eclampsia, but only if you take it regularly. Some pregnant women and people don’t know why or how to take it. Pills can be hard to access, routines tough to build, and advice unclear.

“Drugs don't work in patients who don't take them.” To optimise aspirin for pre-eclampsia prevention, we must go beyond dose and timing. More research is needed to improve real-world implementation and support adherence in the target population.

This is a letter, not a full review, but it highlights an urgent need: better support for real-world adherence. Without it, even the best medicine fails. Let’s rethink how we communicate, supply medicine, support, and individualize aspirin use in pregnancy.

Real-world adherence is a complex issue. Barriers include poor knowledge, limited access, system gaps & weak medication habits. Clinicians must treat adherence as essential!

OBGYN Click on the article title to read more.

Improving Aspirin Adherence for Effective Pre-Eclampsia Prevention

obgyn.onlinelibrary.wiley.com/doi/full/10....

In our @BJOGT letter, we stress: aspirin can prevent pre-eclampsia only if taken.

Trial adherence ≠ real-world use.

Parents to be: Measuring Placental Growth Factor (PlGF) around weeks 12–20 can flag pregnancies at higher risk for high blood pressure complications or early delivery. A normal result is a good sign (≈80–88 % chance of avoiding complications). Talk to your doctor.

In 157 pregnancies, low PlGF at 12–20 weeks tripled the odds of pre eclampsia (OR 2.8) and preterm birth (OR 3.63). Mean birthweight difference wasn’t statistically significant. Findings suggest early placental dysfunction; prospective validation is needed.

Low PlGF early in pregnancy is linked to pre eclampsia and preterm birth; normal levels offer reassurance. Limitations include missing data and limited ethnic diversity. Early PlGF testing may help tailor care in high risk populations.

In our high diabetes cohort, PlGF below the 10th centile at 12–20 weeks predicted pre eclampsia (30% vs 14%) and preterm birth before 37 weeks (50% vs 22 %). Normal PlGF had high negative predictive values (86.5 % for pre eclampsia, 78.4 % for preterm birth).

OBGYN Click on the article title to read more.

Placental Growth Factor (PlGF) Between 12 + 0–20 + 6 Weeks' Gestation and Perinatal Outcomes in a High Prevalent Diabetes Population: A Retrospective Cohort Study

obgyn.onlinelibrary.wiley.com/doi/full/10....

Findings highlight the need for #trauma-informed #culturally responsive care. Clinicians should look out for #nature symbolism in communication, especially when discussing #GBV. Meaningful engagement that acknowledges refugee women's #agency is crucial for #dignified care.

Hope for #bodily autonomy and #FGM/C treatment in resettlement countries is hindered by language barriers, financial constraints and undignified treatment. Informal social networks are pivotal in navigating foreign formal systems.

In our #photovoice study refugee women were #experts narrating stories on their own terms. They used #photography to explore how displacement impacts their #SRH. Findings show how intersecting identities shape SHR experiences and illness only surfaces once #safety is felt.

Whose images count as research? Photographs determine who is visible and who is erased, who counts and who is silenced. Few studies use #visual #participatory methods in #refugee #SRH.

OBGYN Objective To explore how displacement impacts the sexual and reproductive health (SRH) of refugee women. Design Participatory photovoice study integrating photography with qualitative inquiry. S...

Impact of displacement on refugee women's sexual and reproductive health: a participatory study using photovoice

obgyn.onlinelibrary.wiley.com/doi/10.1111/...

OBGYN Click on the article title to read more.

Folks. A commentary to the recent FDA Expert Panel Discussion on the use of #SSRI in #pregnancy in @bjog.bsky.social
Representing The European Network of Teratology Information Services, we do not appreciate with how this unfolded

@mothertobaby.bsky.social #medsinpregnancy @clearyb.bsky.social

OBGYN Objective Spontaneous vaginal births are often the presumed choice, representing 45% of UK births. However, information about benefits and risks is inconsistently given, impacting decision-making an.....

What information do women/birthing people want&need to know about vaginal birth? Find out in @bjog.bsky.social who have today published the vaginal birth core information set! doi.org/10.1111/1471... amazing work from the @theoptionsstudy.bsky.social we hope this supports conversations about birth!

OBGYN Objective To develop a core outcome set (COS) for research on caesarean scar ectopic pregnancy (CSEP) treatment. Design Consensus development study. Setting International. Population Healthcar.....

A Core Outcome Set to Guide Future Research on Caesarean Scar Ectopic Pregnancy: COSCAR Consensus Study

Simrit Nijjar, Ilan Timor-Tritsch, Andrea Kaelin Agten, Jin Li, Krystle Chong, Munira Oza, Rosanna Acklom, et al

obgyn.onlinelibrary.wiley.com/doi/full/10....

@bjog.bsky.social

Starting labour at home (outpatient cervical ripening) is as safe and effective as doing it in hospital. It also has a lower chance of causing stress to the baby (fetal acidosis), making it a good option for some women, depending on their situation.

Outpatient cervical ripening demonstrates equivalent effectiveness and safety profiles compared to the inpatient setting. Notably, it is associated with a significantly lower rate of fetal acidosis.

We acknowledge the loss of raw data from eight randomised trials despite active efforts for more than two years to obtain their data. Three of eight non-shared randomised trials were published before 2010, and their data were unlikely to be available.